Gamma interferon positively modulates Actinobacillus actinomycetemcomitans- specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo

Infection and Immunity

Volumn 73, Issue 6, 2005, Pages 3453-3461

  Teng, Yen Tung A ^a,c   Mahamed, Deeqa ^a   Singh, Bhagirath ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ALVEOLAR BONE; ARTICLE; BACTERIAL INFECTION; BONE DESTRUCTION; BONE REMODELING; CELL ISOLATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; MALE; OSTEOLYSIS; OSTEOPOROSIS; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; TH1 CELL;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; ALVEOLAR BONE LOSS; ANIMALS; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION;

EID: 19744362921     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.6.3453-3461.2005     Document Type: Article

References (54)

1. Anderson, D. M., E. Maraskovsky, W. L. Billingsley, W. Dougall, M. E. Tometsko, E. R. Roux, M. C. Teepe, R. F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179.
2. Azuma, Y., K. Kaji, R. Katogi, S. Takeshita, and A. Kudo. 2000. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275:4858-4864.
3. + T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect. Immun. 67: 2804-2809.
4. Boissier, M. C., G. Chiocchia, N. Bessis, J. Hajnal, G. Garotta, F. Nicoletti, and C. Fournier. 1995. Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur. J. Immunol. 25:1184-1190.
5. Brown, J. M., J. Zhang, and E. T. Keller. 2004. Opg, RANKL and RANK in cancer metastasis: expression and regulation. Cancer Treat. Res. 118:149-172.
6. Canete, J. D., S. E. Martinez, J. Farres, R. Sanmarti, M. Blay, A. Gomez, G. Salvador, and J. Munoz-Gomez. 2000. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann. Rheum. Dis. 59:263-268.
7. Chen, N. J., M. W. Huang, and S. L. Hsieh. 2001. Enhanced secretion of IFN-γ by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J. Immunol. 166:270-276.
8. Choi, Y., K. M. Woo, S. H. Ko, Y. J. Lee, S. J. Park, H. M. Kim, and B. S. Kwon. 2001. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells. Eur. J. Immunol. 31:2179-2188.
9. Clark, W. B., and H. Loe. 1993. Mechanisms of initiation and progression of periodontal disease. Periodontology 2000. 2:72-82.
10. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober. 1996. Current protocols in immunology, vol. 2, suppl. 10, p. 10.23.2. John Wiley & Sons, Inc., New York, N.Y.
11. + myelopoiesis. Arthritis Res. Ther. 6:R220-R231.
12. Ellis, T. N., and B. L. Beaman. 2004. Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology 112:2-12.
13. Fox, S. W., and T. J. Chambers. 2000. Interferon-γ directly inhibits TRANCE-induced osteoclastogenesis. Biochem. Biophys. Res. Commun. 276:868-872.
14. + T cells from localized juvenile periodontitis patients and human peripheral blood leukocyte-reconstituted NOD/SCID mice. J. Periodontol. Res. 37:399-404.
15. Hasegawa, T., Y. Yoshimura, T. Kikuiri, Y. Yawaka, S. Takeyama, A. Matsumoto, H. Oguchi, and T. Shirakawa. 2002. Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligamen T cells. J. Periodontal Res. 37:405-411.
16. Henderson, B., S. P. Nair, J. M. Ward, and M. Wilson. 2003. Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu. Rev. Microbiol. 57:29-55.
17. Herold, K. C. 2004. Achieving antigen-specific immune regulation. J. Clin. Investig. 113:346-349.
18. Hofbauer, L. C., D. L. Lacey, C. R. Dunstan, T. C. Spelsberg, B. L. Riggs, and S. Khosla. 1999. Interleukin-1-beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25:255-259.
19. Hofbauer, L. C., and M. Schoppet. 2004. Clinical implication of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 28:490-495.
20. Honore, P., N. M. Luger, M. A. C. Sabino, M. J. Schwei, S. D. Rogers, and D. B. Mach. 2000. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat. Med. 6:521-528.
21. Josien, R., B. R. Wong, H. L. Li, R. M. Steinman, and Y. Choi. 1999. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J. Immunol. 162:2562-2568.
22. Kawai, T., R. Eisen-Lev, M. Seki, J. W. Eastcott, M. E. Wilson, and M. A. Taubman. 2000. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontitis. J. Immunol. 164: 2102-2109.
23. Kikuchi, T., C. L. Hahn, S. Tanaka, S. E. Barbour, H. A. Schenkein, and J. G. Tew. 2004. Dendritic cells stimulated with Actinobacillus actinomycetemcomitans elicit rapid gamma interferon responses by natural killer cells. Infect. Immun. 72:5089-5096.
24. Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, T. Taniguchi, H. Takayanagi, and T. Takai. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428:758-763.
25. Kong, Y. Y., U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, J. Li, R. Elliott, S. McCabe, T. Wong, G. Campagnuolo, E. Moran, E. R. Bogoch, G. Van, L. T. Nguyen, P. S. Ohashi, D. L. Lacey, E. Fish, W. J. Boyle, and J. M. Penninger. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-308.
26. Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C. R. Dunstan, D. L. Lacey, T. W. Mak, W. J. Boyle, and J. M. Penninger. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
27. Lacey, D. L., E. Timms, H. L. Tan, M. J. Kelly, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y. X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, and W. J. Boyle. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
28. Li, J., I. Sarosi, X. Q. Yan, S. Morony, C. Capparelli, H. L. Tan, S. McCabe, R. Elliott, S. Scully, G. Van, S. Kaufman, S. C. Juan, Y. Sun, J. Tarpley, L. Martin, K. Christensen, J. McCabe, P. Kostenuik, H. Hsu, F. Fletcher, C. R. Dunstan, D. L. Lacey, and W. J. Boyle. 2000. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. USA 97:1566-1571.
29. + T cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice. Diabetes, in press.
30. Mizuno, A., N. Amizuka, K. Irie, A. Murakami, N. Fujise, T. Kanno, Y. Sato, N. Nakagawa, H. Yasuda, S. Mochizuki, T. Gomibuchi, K. Yano, N. Shima, N. Washida, E. Tsuda, T. Morinaga, K. Higashio, and H. Ozawa. 1998. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/ osteoprotegerin. Biochem. Biophys. Res. Commun. 247:610-615.
31. Mochizuki, S., M. Kobayashi, T. Suzuki, A. Oikawa, T. Koseki, T. Nishihara, and K. Hasegawa. 2004. Gamma-interferon enhances expression of CD14/ MyD88 and subsequent responsiveness to lipopolysaccharide from Actinobacillus actinomycetemcomitans in human gingival fibroblasts. J. Periodontal Res. 39:333-343.
32. Nagasawa, T., H. Kobayashi, M. Kiji, M. Aramaki, R. Mahanonda, T. Kojima, Y. Murakami, M. Saito, Y. Morotome, and I. Ishikawa. 2002. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Clin. Exp. Immunol. 130:338-344.
33. Nukaga, J., M. Kobayashi, T. Shinki, H. Song, T. Takada, T. Takiguchi, R. Kamijo, and K. Hasegawa. 2004. Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappa B ligand in human periodontal ligamen T cells. J. Periodontol. 75:249-259.
34. O'Gradaigh, D., D. Ireland, S. Bord, and J. E. Compston. 2004. Joint erosion in rheumatoid arthritis: interactions between tumor necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappa B ligand (RANKL) regulate osteoclasts. Ann. Rheum. Dis. 63:354-359.
35. Ortmann, R. A., and E. M. Shevach. 2001. Susceptibility to collagen-induced arthritis: cytokine-mediated regulation. Clin. Immunol. 98:109-118.
36. Park, S. H., D. J. Min, M. L. Cho, W. U. Kim, J. Youn, W. Park, et al. 2001. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. Arthritis Rheum. 44:561-569.
37. Rani, C. S, and M. MacDougall. 2000. Dental cells express factors that regulate bone resorption. Mol. Cell Biol. Res. Commun. 3:145-152.
38. Romas, E., M. T. Gillespie, M. T., and T. J. Martin. 2002. Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 30:340-346.
39. Ronaghy, A., B. J. Prakken, K. Takabayashi, G. S. Firestein, D. Boyle, N. J. Zvailfler, S. T. Roord, S. Albani, D. A. Carson, and E. Raz. 2002. Immunostimulatory DNA sequences influence the course of adjuvant arthritis. J. Immunol. 168:51-56.
40. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, M., R. Elliott, A. Colombero, H. L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T. M. Hughes, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van, J. Tarpley, P. Derby, R. Lee, and W. J. Boyle. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
41. Takada, Y., and B. B. Aggarwal. Posting date, 17 August 2004. Evidence that genetic deletion of the TNF receptor p60 or p80 in macrophages modulates RANKL-induced signaling. Blood 104:4113-4121. [Online.]
42. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, et al. 2000. T cell mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature 408:600-605.
43. Taubman, M. A., and T. Kawai. 2001. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit. Rev. Oral Biol. Med. 12:125-135.
44. Teng, Y.-T. A. 2002. Mixed periodontal Th1-Th2 cytokine profile in Actinobacillus actinomycetemcomitans-specific osteoprotegerin ligand (or RANK-L)-mediated alveolar bone destruction in vivo. Infect. Immun. 70: 5269-5273.
45. Teng, Y.-T. A. 2003. The role of acquired immunity and periodontal disease progression. Crit. Rev. Oral Biol. Med. 14:237-252.
46. Teng, Y.-T. A., H. Nguyen, X. Gao, Y. Y. Kong, R. M. Gorczynski, B. Singh, R. P. Ellen, and J. M. Penninger. 2000. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J. Clin. Investig. 106:R59-R67.
47. Teng, Y.-T. A.. H. Nguyen, A. Hassanloo, R. P. Ellen, H. Hozumi, and R. M. Gorczynski. 1999. Periodontal immune responses of human lymphocytes in Actinobacillus actinomycetemcomitans-inoculated NOD/SCID mice engrafted with peripheral blood leukocytes of periodontitis patients. J. Periodontol. Res. 34:54-61.
48. Teng, Y.-T. A., and W. Hu. 2003. Expression cloning of a periodontitis-associated apoptotic effector, cage homologue, in Actinobacillus actinomycetemcomitans. Biochem. Biophys. Res. Commun. 303:1086-1094.
49. Teng, Y.-T. A., and X. Zhang. 2005. Apoptotic activity and sub-cellular localization of a T4SS-associated CagE-homologue in Actinobacillus actinomycetemcomitans. Microb. Pathog. 38:125-132.
50. Theill, L. E., W. J. Boyle, and J. M. Penninger. 2002. RANK-L and RANK: T cell, bone loss and mammalian evolution. Annu. Rev. Immunol. 20:795-823.
51. Valverde, P., T. Kawai, and M. A. Taubman. 2004. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. J. Bone Miner. Res. 19:155-164.
52. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, and A. Murakami. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis- inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95:3597-3602.
53. Wong, B. R., R. Josien, S. Y. Lee, B. Sauter, H. L. Li, R. M. Steinman, and Y. Choi. 1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186:2075-2080.
54. Zamhon, J. J., T. Umemoto, E. De Nardin, F. Nakazawa, J. A. Christersson, and R. J. Genco. 1988. Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease. Adv. Dent. Res. 2:269-274.